Fundraising Fox
/Companies
Sign in

Serinus Biosciences

YC S22

New York City, US · Founded 2022 · 6 employees · 12 known investors

Find your way into Serinus Biosciences

Sign up to see every warm intro you have to Serinus Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Serinus Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.

Also known as Serinus

BiotechHealthtechTherapeuticsOncologyUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (S22)

Serinus Biosciences was founded in 2022 by Adam Yaari and Maxwell Sherman.

AYAdam Yaari
Adam YaariCo-founder · Chair of the Board of DirectorsAdam Yaari holds a PhD and MS in computer science from MIT, an MSc in computer science and mathematics from the Weizmann Institute of Science, and a BSc in computer science and neuroscience from Bar-Ilan University. He brings over a decade of entrepreneurial experience, including roles as a Microsoft R&D Fellow and Flagship Pioneering Ideation Fellow, and founded Serinus Biosciences to develop AI models for biological research.
MSMaxwell Sherman
Maxwell ShermanCo-founder & CTOMaxwell Sherman worked as a paramedic for five years before pursuing advanced studies in applied mathematics and biology at Brown University, statistics at Cambridge University, and computational biology at MIT, where he completed a PhD. His research has been published in major peer-reviewed journals.

Investors · 12

Metaplanetlisted by MetaplanetTallinn · $500K – $10M

How we know: Metaplanet's portfolio page · the VCSheet dataset · Not right? Tell us

Pioneerlisted by PioneerToronto, Ontario

How we know: Y Combinator's founder network · pioneerfund.vc · Not right? Tell us

Sapir Venture Partnerslisted by Sapir Venture PartnersJerusalem

How we know: Sapir Venture Partners's portfolio page · Not right? Tell us

Vertex Ventures Israellisted by Vertex Ventures IsraelTel Aviv-Yafo · $1M – $10M

How we know: Vertex Ventures Israel's portfolio page · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

AlexandriareportedPasadena

How we know: Y Combinator's founder network · Not right? Tell us

Asymmetry VenturesreportedRichmond · $125K – $500K

How we know: Y Combinator's founder network · Not right? Tell us

Nadav RosenbergreportedCanterbury

How we know: Y Combinator's founder network · Not right? Tell us

NKM CapitalreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Phoenix FundreportedNew York

How we know: Y Combinator's founder network · Not right? Tell us

Vertex VenturesreportedPalo Alto · $500K – $10M

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 10

Seran BioscienceSerán is a contract development and manufacturing organization (CDMO) that provides drug formulation, development, and manufacturing services to pharmaceutical companies. The company specializes in process engineering, scaleup, and commercial manufacturing of solid dosage forms and advanced pharmaceutical technologies.
Adventris PharmaceuticalsAdventris is a biotechnology company developing cancer immunotherapy treatments.
Velorum TherapeuticsVelorium develops transformational medicines by combining scientific research with patient-focused collaboration. The company operates in the medical research and therapeutic development space.
Granza BioGranza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.
Precision BioSciencesPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
AlixiaAlixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases. The company integrates biology, biophysics, and computational chemistry to design compounds that disrupt metabolic and inflammatory triggers in multiple cell types within the tumor microenvironment.
Talus BioTalus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts. The company designs AI-driven compounds and uses functional proteomics to enable drug discovery for transcription factors and regulatory proteins implicated in oncology, rare disease, and immune dysfunction.
Kopra BioKopra Bio develops cancer immunotherapy technology that converts cancer cells into biofactories to produce their own destruction. The company operates in the biotech and cancer treatment space.
Seres TherapeuticsSeres Therapeutics is a clinical-stage biotechnology company developing therapies composed of rationally selected live bacterial consortia to treat serious diseases through modulation of the human microbiome. The company pioneered the development and FDA approval of VOWST, an oral live biotherapeutic.
SerinuslabsSerinus Labs develops semiconductor-based sensing systems that detect and interpret chemical signals for practical applications. The company emerged from UC Berkeley research and designs sensor technologies intended for high-volume silicon manufacturing and field deployment.

Companies working in the same space as Serinus Biosciences.

Legal entities · 1

corporate structure
Serinus Biosciences Inc.

In the news

Serinus Biosciences Funding | $0-1M Revenue | Complete Analysis | Extruct AIextruct.ai · Sep 2022Serinus Biosciences: Killing cancer with its own genetics 💪🏽ycombinator.com · Aug 2022

Frequently asked questions

What does Serinus Biosciences do?
Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.
Who founded Serinus Biosciences?
Serinus Biosciences was founded by Adam Yaari, Maxwell Sherman in 2022.
Who are Serinus Biosciences's investors?
Serinus Biosciences's investors include Illumina Ventures, Metaplanet, Pioneer, Sapir Venture Partners, Vertex Ventures Israel, Y Combinator, Alexandria, Asymmetry Ventures and 4 more.
Where is Serinus Biosciences headquartered?
Serinus Biosciences is headquartered in New York City, US.